Strainsforpains, Inc.
EBYH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.06 | 0.62 | 1.33 | -0.23 |
| FCF Yield | -6.86% | -8.96% | -4.94% | -10.09% |
| EV / EBITDA | 56.00 | -71.50 | -60.97 | -38.18 |
| Quality | ||||
| ROIC | 4.98% | -4.26% | -7.14% | -8.76% |
| Gross Margin | 0.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 6.04 | 1.36 | 1.00 | 1.25 |
| Growth | ||||
| Revenue 3-Year CAGR | 189.97% | 109.82% | -30.01% | -1.23% |
| Free Cash Flow Growth | 22.42% | -11.35% | 27.93% | 81.23% |
| Safety | ||||
| Net Debt / EBITDA | 23.05 | -29.44 | -18.32 | -14.71 |
| Interest Coverage | 0.73 | -0.56 | -0.90 | -1.12 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 455.68 | 282.05 | 0.00 | 0.00 |